Holly Uppal

PHD Doctor of Philosophy,  Toronto General - University Health Network 

Location: Africa

Consulting Services

Grant Submission Hospital-Pharmacy-Insurance

Areas Of Interest

Pygmy Chimpanzees Capacitation of Spermatozoa Cytochrome P-450-Dependent Monooxygenase Inhibitors Cystamine Dihydrobromide Chicken Anemia Agents Aminoacridine Hypertrophic Osteoarthropathy, Secondary Reflex, Triceps, Decreased Stimulus Responsive Polymers Chain Pickerel Health Facility Environment Equivalency, Therapeutic Myopathies, X-Linked Myotubular Anchor, Suture Methylgalactosides Pactamycin Thromboglobulin, beta-2 Encephalitis, European Tick-Borne Fluortriamcinolone Acetonide Acetylases, Arylamine Na-Cl-Symporters Chromatography, Gas-Liquid-Mass Spectrometry Protea Plants Dentate Nucleus Mosquitoes Anaplasmataceae Infections Ribonucleoprotein, U4-U6 Small Nuclear

Professional Narrative

Dr. Holly Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Harvard Med 1990
Executive Director, Amgen 2018

Education

Bachelor of science in nursing, Weill Medical College 1989
Doctor of osteopathic medicine, Harvard Medical School 1987

Referees

Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02